Skip to main content
Back
Activeted-345828-2026

Discount Agreements for Lipegfilgrastim

The Techniker Krankenkasse aims to enter into discount agreements for the active ingredient Lipegfilgrastim. The goal is to establish contracts with suitable pharmaceutical companies according to § 130a (8) SGB V.

View original source

CONTRACTING AUTHORITY

Name

Techniker Krankenkasse

City

Hamburg

Country

DE

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000, Pharmaceutical products.

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

No

Electronic Submission

not-allowed

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

772 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

772 days remaining

Similar Tenders

Explore CPV 33

Discount Agreements for Interferon beta-1b (Betaferon®)

The Techniker Krankenkasse aims to establish discount agreements for the medication Betaferon® with pharmaceutical companies. The goal is to reduce costs for Interferon beta-1b.

Techniker Krankenkasse

·Hamburg
Deadline:June 30, 2028

Discount Agreements for Epoetin theta

The Techniker Krankenkasse aims to establish discount agreements for the active ingredient Epoetin theta to ensure supply and optimize costs.

Techniker Krankenkasse

·Hamburg
Deadline:June 30, 2028

Discount Agreements for Ranibizumab

The Techniker Krankenkasse aims to establish discount agreements for the active ingredient Ranibizumab to achieve cost-effectiveness. This concerns the biologics sector for the year 2026.

Techniker Krankenkasse

·Hamburg
Deadline:June 30, 2027

Discount Agreements for Ranibizumab

We are seeking partners for drug discount agreements for the active ingredient Ranibizumab through an open-house procedure. The goal is to ensure supply and cost-effectiveness.

Techniker Krankenkasse

·Hamburg
Deadline:June 30, 2026

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now